IP Library Granted Patent US 10,660,798
Granted Patent B2
US 10,660,798 · App. 15/667,567 · Granted May 26, 2020

Devices for protecting vulnerable sites on patients from liquid contamination and related devices, systems, and methods

Inventors: Art Seguin (West Jordan, UT); Gerry Arambula (Seattle, WA)
Assignee: COVALON TECHNOLOGIES AG LTD.
A61F13/00063A61F13/0203A61F13/12A61B2046/205A61F15/004A61F15/008A61F2013/00272
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,660,798
App. No.
15/667,567
Granted
May 26, 2020
Kind
B2
Abstract

A protective device configured in accordance with a particular embodiment includes a cover including a first region that extends over a vulnerable site on a patient and a second region that extends over an area on the patient peripheral to the vulnerable site. The first region of the cover is at least generally impermeable to liquid water. The device further includes an adhesive film and a liquid-absorbing element. The adhesive film is configured to form an adhesive bond between the second region of the cover and the patient. The bond has an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site. The liquid-absorbing element is configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient.

Claims (30)

1. A protective device, comprising:

a cover configured to be operably positioned on a human patient such that a first region of the cover extends over a vulnerable site on the patient and a second region of the cover extends over an area on the patient peripheral to the vulnerable site, the first region of the cover being at least generally impermeable to liquid water;

an adhesive film configured to form an adhesive bond between the second region of the cover and the patient, the bond having an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site when the cover is operably positioned on the patient; and

a liquid-absorbing element attached to the cover and configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient, at least a portion of the liquid-absorbing element being positioned further from the vulnerable site than the outer edge portion of the bond when the cover is operably positioned on the patient.

2. The protective device of claim 1 wherein the second region of the cover is at least generally impermeable to liquid water.

3. The protective device of claim 1 wherein the bond is a direct bond between the second region of the cover and the patient.

4. The protective device of claim 1 wherein the liquid-absorbing element is configured to wick liquid contamination away from the outer edge portion of the bond.

5. The protective device of claim 1 wherein the first region of the cover is permeable to water vapor.

6. The protective device of claim 1 wherein the first region of the cover is impermeable to water vapor.

7. The protective device of claim 1 wherein the first region of the cover is a region of a three-dimensional shell configured to at least partially encase a three-dimensional space adjacent to the vulnerable site when the cover is operably positioned on the patient.

8. The protective device of claim 1 wherein the liquid-absorbing element includes an antimicrobial agent.

9. The protective device of claim 1 wherein:

the adhesive film extends around from about 10% to about 90% of a perimeter of the first region of the cover; and

the cover includes a third region at a portion of the perimeter of the first region of the cover along which the adhesive film does not extend, the third region being configured to allow ventilation of the vulnerable site when the cover is operably positioned on the patient.

10. The protective device of claim 1 wherein the cover is flexible and configured to drape over a percutaneous device at the vulnerable site when the cover is operably positioned on the patient.

11. A protective device, comprising:

a cover configured to be operably positioned on a human patient such that a first region of the cover extends over a vulnerable site on the patient, a second region of the cover extends over an area on the patient peripheral to the vulnerable site, a first side of the second region of the cover faces toward the patient, and a second side of the second region of the cover faces away from the patient, the first region of the cover being at least generally impermeable to liquid water;

an adhesive film disposed along the first side of the second region of the cover, the adhesive film being configured to form an adhesive bond between the second region of the cover and the patient, the bond having an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site when the cover is operably positioned on the patient; and

a liquid-absorbing element disposed along the second side of the second region of the cover and configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient.

12. The protective device of claim 11 wherein the second region of the cover is at least generally impermeable to liquid water.

13. The protective device of claim 11 wherein the bond is a direct bond between the second region of the cover and the patient.

14. The protective device of claim 11 wherein the liquid-absorbing element is configured to wick liquid contamination away from the outer edge portion of the bond.

15. The protective device of claim 11 wherein the first region of the cover is permeable to water vapor.

16. The protective device of claim 11 wherein the first region of the cover is impermeable to water vapor.

17. The protective device of claim 11 wherein the first region of the cover is a region of a three-dimensional shell configured to at least partially encase a three-dimensional space adjacent to the vulnerable site when the cover is operably positioned on the patient.

18. The protective device of claim 11 wherein the liquid-absorbing element includes an antimicrobial agent.

19. The protective device of claim 11 wherein:

the adhesive film extends around from about 10% to about 90% of a perimeter of the first region of the cover; and

the cover includes a third region at a portion of the perimeter of the first region of the cover along which the adhesive film does not extend, the third region being configured to allow ventilation of the vulnerable site when the cover is operably positioned on the patient.

20. The protective device of claim 11 wherein the cover is flexible and configured to drape over a percutaneous device at the vulnerable site when the cover is operably positioned on the patient.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS THE AGENT
To: TIDI AQUAGUARD OPERATIONS LLC (FORMERLY KNOWN AS TIDI AQUAGUARD OPERATIONS INC., FORMERLY KNOWN AS COVALON TECHNOLOGIES AG LTD.)
Reel/Frame 066079/0760 →
SECURITY INTEREST Recorded Dec 27, 2023
From: TIDI PRODUCTS, LLC; PENBLADE, LLC
To: ADAMS STREET CREDIT ADVISORS LP, AS COLLATERAL AGENT
Reel/Frame 066126/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2022
From: TIDI AQUAGUARD OPERATIONS, LLC
To: TIDI PRODUCTS, LLC
Reel/Frame 059794/0422 →
ENTITY CONVERSION Recorded Jan 4, 2022
From: TIDI AQUAGUARD OPERATIONS INC.
To: TIDI AQUAGUARD OPERATIONS LLC
Reel/Frame 058575/0341 →
SECURITY INTEREST Recorded Aug 18, 2021
From: TIDI AQUAGUARD OPERATIONS INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 057217/0270 →
CHANGE OF NAME Recorded Aug 11, 2021
From: COVALON TECHNOLOGIES AG LTD.
To: TIDI AQUAGUARD OPERATIONS INC.
Reel/Frame 057177/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2019
From: CENORIN, LLC
To: COVALON TECHNOLOGIES AG LTD.
Reel/Frame 048031/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2018
From: SEGUIN, ART; ARAMBULA, GERRY
To: CENORIN, LLC
Reel/Frame 047820/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: CENORIN, LLC
To: COVALON TECHNOLOGIES AG LTD.
Reel/Frame 047711/0776 →
Continuity (3)
Continuation 14225268 · Mar 25, 2014
Provisional Application 61805483 · Mar 26, 2013
Related Publication 20180008472A1 · Jan 11, 2018